RSV

People who are immunocompromised may not produce enough protective antibodies against RSV after vaccination - EurekAlert

People who are immunocompromised may not produce enough protective antibodies against RSV after vaccination

Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued - EurekAlert

Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued

‘Safety signal’ in Moderna’s RSV vaccine studies halts trials of other vaccines for childhood killer

Researchers use biophysics to design new vaccines against RSV and related respiratory viruses

Study reveals best timing for getting the RSV vaccine during pregnancy to protect newborns

RSV vaccines effective, but more people need to get them

Big data, real world, multi-state study finds RSV vaccine highly effective in protecting older adults against severe disease, hospitalization and death

Researchers identify signs tied to more severe cases of RSV

New images of RSV may expose stubborn virus’s weak points - EurekAlert

New images of RSV may expose stubborn virus's weak points

RSV Can Be a Killer. New Tools Are Identifying the Most At-Risk Kids

New RSV vaccine for older adults can result in individual and societal cost savings, benefits

Scientists pinpoint new drug target for RSV

RSV monoclonal antibody nirsevimab 83% effective in babies

Study backs RSV vaccine safety during pregnancy

New tool may help prioritize high-risk infants for RSV immunization

New tool may help prioritize high-risk infants for RSV immunization - EurekAlert

For 60+ years, respiratory syncytial virus (RSV) vaccines have evaded scientists. But now that's changed [Sponsored]